{
  "created_at": "Mon Jul 26 3:25:19 +0000 2021",
  "id_str": "1419487829349044225",
  "full_text": "AstraZeneca, the one vaccine of which Australia has plenty, is only given to the over-60s. This is one reason why vaccination rates are low: just 15% of the adult population has been jabbed https://t.co/xBupVlDVxp",
  "display_text_range": [
    0,
    213
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/xBupVlDVxp",
        "expanded_url": "https://econ.st/3yeo2fP",
        "display_url": "econ.st/3yeo2fP",
        "indices": [
          190,
          213
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 34,
  "favorite_count": 89,
  "possibly_sensitive": false,
  "original_created_at": "Mon Jul 26 02:40:45 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "アストラゼネカは、オーストラリアに豊富にあるワクチンのうち、60歳以上の方にのみ投与されています。これがワクチン接種率が低い理由のひとつで、成人人口のわずか15％がワクチンを接種しています。https://t.co/xBupVlDVxp"
    },
    {
      "locale": "zh",
      "full_text": "AstraZeneca，澳大利亚有大量的这种疫苗，只给60岁以上的人使用。这是疫苗接种率低的一个原因：只有15%的成年人口接种过https://t.co/xBupVlDVxp。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "AstraZeneca，澳大利亞有大量的這種疫苗，只給60歲以上的人使用。這是疫苗接種率低的一個原因：只有15%的成年人口接種過https://t.co/xBupVlDVxp。"
    }
  ]
}